Sbir phase I topic #439 - advanced sample processing platforms for downstream single-cell multi-omic analysis
Ended Definitive Contract Awarded Last action
- Contract number
- 75N91022C00061
- Awardee
-
Enrich Biosystems Inc. UEI M6XYEESK8AS8
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $399,761
Award facts
- Opportunity
-
- A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proposals Pre-Solicitation · PHS20221 · Posted Jul 12, 2021
- Contract value 88% obligated
-
- $399,761.00 Current, with exercised options
- $454,751.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 3 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Branford, CT 06405, USA
- Research
- SBIR Program Phase I Action
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Vendor DUNS or Name Change - Non-Novation | $0 | |
| Other Administrative Action | $0 | |
| Original award | $399,761 |
About this award
This $454,751 firm fixed price Small Business Innovation Research (SBIR) Phase I contract was awarded to Enrich Biosystems Inc. by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH). The 24-month research project will develop advanced sample processing platforms for downstream single-cell multi-omic analysis to support biomedical research and precision medicine efforts. This contract is set aside for small businesses and builds on Enrich Biosystems' prior SBIR and NIH grant funding for single-cell isolation and analysis technologies. The original SBIR solicitation listed this Topic #439 as part of a broader NIH and Centers for Disease Control and Prevention (CDC) SBIR program focused on mission-oriented research topics across infectious diseases, cancer, aging, and public health.
Quick answers
Who was awarded contract 75N91022C00061?
75N91022C00061 was awarded to Enrich Biosystems Inc. by National Cancer Institute (National Institutes of Health) on September 19, 2022.
How much is contract 75N91022C00061 worth?
The government has obligated $399,761 on 75N91022C00061. Its potential value, with all options, is $454,751.
Was contract 75N91022C00061 competed?
The extent of competition for 75N91022C00061 was full and open competition after exclusion of sources. The government received 3 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award